Related Experiment Video
Updated: Jun 8, 2026

02:21
Microscopic Electric Rotary Grinding of Plaques Combined with Graft Repair in the Management of Peyronie's Disease
Published on: March 15, 2024
Ischemic priapism and implant surgery with sharp corporal fibrosis excision
Doron S Stember1, John P Mulhall1
1Memorial Sloan-Kettering Cancer Center-Urology, New York, NY.
The Journal of Sexual Medicine
|October 9, 2010
Summary
Proper intracavernosal injection therapy prevents priapism complications like erectile dysfunction and corporal fibrosis. Careful patient training and monitoring are essential for safe sexual dysfunction management.
Area of Science:
- Urology
- Sexual Medicine
- Andrology
Background:
- Prolonged ischemic priapism frequently leads to severe erectile dysfunction.
- Corporal tissue fibrosis complicates subsequent penile implant surgery.
Observation:
- Intracavernosal injection therapy requires careful clinical practice for safe and effective use.
- Management of erectile dysfunction resulting from priapism treatment is crucial.
Findings:
- Distinguishing erectile dysfunction from premature ejaculation is vital.
- Patient training and monitoring are essential to prevent priapism from self-injection therapy.
- Corporal fibrosis development is duration-dependent during prolonged ischemic priapism.
- Implant surgeons must be adept at managing fibrotic corporal tissue.
Implications:
- Safe management of sexual dysfunction requires distinguishing conditions and proper patient education.
- Financial motivations in injection clinics can compromise patient care.
- Surgical techniques must address corporal fibrosis for successful penile prosthesis implantation.
